IgA Nephropathy Market Growth, Analysis, Trends and Forecast 2023 to 2033

The global IgA Nephropathy Market is expected to generate a market value of US$ 41.24 billion in 2023 and a market value of US$ 85 billion by 2023 to 2033, at a CAGR of 7.5%. The increasing prevalence of kidney diseases among various age groups can be attributed to the growth of the IgA nephropathy market. In the historical period 2017-2022, the market for IgA nephropathy grew at a CAGR of 4.8%.

FMI, in its business report, elaborates the historical and current scenario of the global IgA Nephropathy Market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

IgA Nephropathy Market: Segmentation

Valuable information covered in the FMI’s IgA Nephropathy market report has been segregated into key segments and sub-segments.

Diagnosis:

  • Iothalamate Clearance Test
  • Kidney Biopsy
  • Blood Tests
  • Urine Tests

Diseases Type:

  • Primary IgA Nephropathy
  • Secondary IgA Nephropathy

Systems:

  • Hematuria
  • Proteinuria
  • Edema
  • Others

Population Type:

  • Pediatrics
  • Adults

Route of Administration:

  • Oral
  • Parenteral
  • Others

Treatment:

  • Medication
  • Statin therapy
  • Omega-3 fatty acids
  • Angiotensin-converting enzyme (ACE) inhibitors
  • Angiotensin receptor blockers (ARBs)
  • Diuretics
  • Immunosuppressants
  • Kidney Transplantation
  • Others

End Users:

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Get More Details@ https://www.futuremarketinsights.com/reports/iga-nephropathy-market

IgA Nephropathy Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the IgA Nephropathy market. Competitive information detailed in the IgA Nephropathy market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the IgA Nephropathy market report.

Key players covered in the report include:

  • Calliditas Therapeutics AB
  • Travere Therapeutics, Inc.
  • Omeros Corporation
  • Novartis Pharmaceuticals
  • Chinook Therapeutics, Inc.
  • Vera Therapeutics, Inc.
  • Otsuka Pharmaceutical
  • Alembic Pharmaceuticals Limited
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson Private Limited

Comments

Post a Comment

Popular posts from this blog

Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

Image
According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033. Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world. Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to prod...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Cognitive Diagnostics Market Projected to Reach Unprecedented Growth by 2033

Image
As per Future Market Insights latest industry analysis, the valuation for the global  Cognitive Diagnostics market sales  is estimated to reach US$ 110.2 Billion in 2023 and is projected to exhibit a CAGR of 8.0% over the forecast period, with an estimated valuation of US$ 238.3 Billion by 2033. Several causes of brain problems or cognitive disorders include closed head injuries, contact with neurotoxins (toxic substances), genetics, infections, strokes, and tumours. Depending on the area of the brain that is impacted, a person may have a certain form of cognitive problem. Communication issues could result from, for instance, a tumour in the speech cisterns of the brain. In another illustration, a brain infection that affects the motor recentres would cause problems with movement. Ageing is also a factor in the development of cognitive problems. Cognitive diagnostics increasingly use digital health technologies like wearables and smartphone apps. These tools can monitor a pati...
Read more